StockWireNews
Could This Tiny Float Biopharma (Nasdaq) Become 2023's Next Breakout Target 2023? (Explosive Chart History)
Full Report Arrives At 8:00PM EST Tonight
Sign Up To My SMS Update System - Directions Below
March 8th
Greetings Readers,
Let's recap my first profile from this week real quick.
For Tuesday's opening bell, I delivered a new Nasdaq breakout idea.
It made a strong 2-day surge from an open of $1.61 to a $1.90 high as of writing Wednesday.
That run resulted in an approximate 18% move which may only be the start.
Remember, I've alerted that breakout idea before only for it to pop-off big-time within 3 weeks on each occasion.
While I recommend watching that one closely moving forward, there is also a new Nasdaq breakout idea I'm profiling and suggesting you to get on radar immediately.
At 8:00PM EST tonight, the complete report arrives (company name and symbol).
And based on 3 potential catalysts you can see right now, it may have the market looking its way in the blink of an eye.
Check this out:
3 Potential Breakout Catalysts - Important Must-See Details Right Now
#1. It's a low float profile. With fewer than 6Mn shares in its float, this Biopharma profile could be ripe for daily volatility.
#2. An explosive chart history. On several occasions over the previous 6 months, this Nasdaq idea has put together $1.00+ intraday surges.
#3. The company sees tons of potential in large underserved markets with over 25Mn patients in the US alone suffering from specific disorders and diseases.
With no new FDA approved therapies in multiple decades for these disorders/diseases, this company could be uniquely situated to create a game-changing treatment.
This will help when the new report arrives:
